Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2021
Neurocrine sues Lupin over Ingrezza patents
Neurocrine Biosciences filed suit against Lupin, alleging infringement of three patents protecting Ingrezza. Lupin disputed infringement in its ANDA, while Neurocrine sought a judgment and an injunction.